Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 4:35 PM View:  | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Payment of Exercise | 3,957 | $4.51 | $17,846.10 | (11%) 34.51K to 30.55K | |
| 23-Apr-24 4:39 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Option Exercise | 5,625 | -- | -- | 87% 6.43K to 12.06K | |
| 23-Apr-24 4:35 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Option Exercise | 16,250 | -- | -- | 89% 18.26K to 34.51K | |
| 23-Apr-24 4:26 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Payment of Exercise | 6,088 | $4.51 | $27,456.90 | (6%) 101.72K to 95.64K | |
| 23-Apr-24 4:31 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Payment of Exercise | 10,125 | $4.51 | $45,663.80 | (17%) 61.0K to 50.88K | |
| 23-Apr-24 4:26 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Option Exercise | 25,000 | -- | -- | 33% 76.72K to 101.72K | |
| 23-Apr-24 4:31 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Option Exercise | 22,500 | -- | -- | 58% 38.5K to 61.0K | |
| 23-Apr-24 4:39 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 19-Apr-24 | Payment of Exercise | 2,250 | $4.51 | $10,147.50 | (19%) 12.06K to 9.81K | |
| 06-Mar-24 4:43 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 04-Mar-24 | Private Purchase | 10,000 | $4.59 | $45,850.00 | 15% 66.72K to 76.72K | |
| 06-Mar-24 4:49 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 04-Mar-24 | Private Purchase | 10,000 | $4.59 | $45,850.00 | 35% 28.5K to 38.5K | |
| 01-Jun-23 5:42 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 30-May-23 | Private Purchase | 5,000 | $5.50 | $27,500.00 | 8% 61.73K to 66.73K | |
| 01-May-23 5:53 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Option Exercise | 7,500 | -- | -- | 13% 56.06K to 63.56K | |
| 01-May-23 5:51 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Payment of Exercise | 2,250 | $8.29 | $18,652.50 | (7%) 31.99K to 29.74K | |
| 01-May-23 5:53 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Payment of Exercise | 1,827 | $8.29 | $15,145.80 | (3%) 63.56K to 61.73K | |
| 01-May-23 5:55 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Option Exercise | 1,250 | -- | -- | 21% 5.85K to 7.1K | |
| 01-May-23 5:54 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Option Exercise | 2,500 | -- | -- | 15% 16.37K to 18.87K | |
| 01-May-23 5:51 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Option Exercise | 5,000 | -- | -- | 19% 26.99K to 31.99K | |
| 01-May-23 5:55 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Payment of Exercise | 669 | $8.29 | $5,546.01 | (9%) 7.1K to 6.43K | |
| 01-May-23 5:54 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-23 | Payment of Exercise | 609 | $8.29 | $5,048.61 | (3%) 18.87K to 18.26K | |
| 24-Apr-23 4:13 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Payment of Exercise | 7,324 | $6.80 | $49,803.20 | (12%) 61.92K to 54.6K | |
| 24-Apr-23 4:17 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Option Exercise | 5,625 | -- | -- | 174% 3.24K to 8.86K | |
| 24-Apr-23 4:14 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Option Exercise | 16,250 | -- | -- | 413% 3.93K to 20.18K | |
| 24-Apr-23 4:15 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Option Exercise | 22,500 | -- | -- | 154% 14.62K to 37.12K | |
| 24-Apr-23 4:17 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Payment of Exercise | 3,010 | $6.80 | $20,468.00 | (34%) 8.86K to 5.85K | |
| 24-Apr-23 4:14 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Payment of Exercise | 4,819 | $6.80 | $32,769.20 | (24%) 20.18K to 15.36K | |
| 24-Apr-23 4:13 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Option Exercise | 25,000 | -- | -- | 68% 36.92K to 61.92K | |
| 24-Apr-23 4:15 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 21-Apr-23 | Payment of Exercise | 10,125 | $6.80 | $68,850.00 | (27%) 37.12K to 26.99K | |
| 21-Nov-22 2:27 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 18-Nov-22 | Purchase | 22,000 | -- | -- | 147% 14.92K to 36.92K | |
| 18-Aug-22 4:38 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 16-Aug-22 | Payment of Exercise | 266 | $4.37 | $1,162.42 | (8%) 3.5K to 3.24K | |
| 18-Aug-22 4:39 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 16-Aug-22 | Grant | 1,817 | $4.37 | $7,940.29 | 86% 2.11K to 3.93K | |
| 18-Aug-22 4:39 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 16-Aug-22 | Grant | 3,059 | $4.37 | $13,367.80 | 26% 11.86K to 14.92K | |
| 18-Aug-22 4:38 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 16-Aug-22 | Grant | 2,827 | $4.37 | $12,354.00 | 419% 0.68K to 3.5K | |
| 29-Apr-22 4:39 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Option Exercise | 7,500 | -- | -- | 121% 6.19K to 13.69K | |
| 29-Apr-22 4:46 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Payment of Exercise | 2,250 | $7.43 | $16,717.50 | (13%) 16.87K to 14.62K | |
| 29-Apr-22 4:50 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Payment of Exercise | 669 | $7.43 | $4,970.67 | (50%) 1.34K to 0.68K | |
| 29-Apr-22 4:51 PM View: | Clarke Anthony CSO | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Payment of Exercise | 250 | $7.43 | $1,857.50 | (4%) 6.43K to 6.18K | |
| 29-Apr-22 4:43 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Payment of Exercise | 609 | $7.43 | $4,524.87 | (22%) 2.72K to 2.11K | |
| 29-Apr-22 4:46 PM View: | Stewart Richard Alistair Executive Chairman Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Option Exercise | 5,000 | -- | -- | 42% 11.87K to 16.87K | |
| 29-Apr-22 4:50 PM View: | Wann Jerry Principal Accounting Officer | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Option Exercise | 1,250 | -- | -- | 1330% 94 to 1.34K | |
| 29-Apr-22 4:51 PM View: | Clarke Anthony CSO | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Option Exercise | 1,000 | -- | -- | 18% 5.43K to 6.43K | |
| 29-Apr-22 4:39 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Payment of Exercise | 1,827 | $7.43 | $13,574.60 | (13%) 13.69K to 11.86K | |
| 29-Apr-22 4:43 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 28-Apr-22 | Option Exercise | 2,500 | -- | -- | 1121% 0.22K to 2.72K | |
| 19-Aug-21 5:09 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 17-Aug-21 | Option Exercise | 68 | -- | -- | 39% 0.18K to 0.24K | |
| 19-Aug-21 5:09 PM View: | Jacobs Cindy President & CMO Director | Sonus Pharmaceuticals Inc. (ACHV) | 17-Aug-21 | Payment of Exercise | 21 | $6.81 | $143.01 | (9%) 0.24K to 0.22K | |
| 27-May-21 4:10 PM View: | Bencich John CEO Director | Sonus Pharmaceuticals Inc. (ACHV) | 27-May-21 | Private Purchase | 6,000 | $7.00 | $42,000.00 | 4255% 0.14K to 6.14K | |
| 19-Aug-20 4:25 PM View: | Jacobs Cindy EVP, CMO | Sonus Pharmaceuticals Inc. (ACHV) | 18-Aug-20 | Payment of Exercise | 33 | $8.95 | $295.35 | (16%) 0.21K to 0.18K | 16% |
| 19-Aug-20 4:26 PM View: | Bencich John CFO & COO | Sonus Pharmaceuticals Inc. (ACHV) | 18-Aug-20 | Option Exercise | 69 | -- | -- | 66% 0.1K to 0.17K | |
| 19-Aug-20 4:25 PM View: | Jacobs Cindy EVP, CMO | Sonus Pharmaceuticals Inc. (ACHV) | 18-Aug-20 | Option Exercise | 69 | -- | -- | 49% 0.14K to 0.21K | |
| 19-Aug-20 4:26 PM View: | Bencich John CFO & COO | Sonus Pharmaceuticals Inc. (ACHV) | 18-Aug-20 | Payment of Exercise | 33 | $8.95 | $295.35 | (19%) 0.17K to 0.14K | 16% |
| 15-Aug-19 5:10 PM View: | Bencich John CFO & COO | Sonus Pharmaceuticals Inc. (ACHV) | 13-Aug-19 | Payment of Exercise | 408 | $1.88 | $767.04 | (16%) 2.51K to 2.1K | 79% |
